We are live on ! Find out more
QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $55.6M
1-Year Est. Return 98.09%
This Fund
S&P 500
This Quarter Est. Return
-43.44%
1 Year Est. Return
+98.09%
3 Year Est. Return
+1,484.17%
5 Year Est. Return
10 Year Est. Return
AUM
$106M
AUM Growth
-$111M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRML
1
DELISTED
Tourmaline Bio
TRML
$28.9M 27.11%
293,261
ICVX
2
DELISTED
Icosavax, Inc. Common Stock
ICVX
$24.7M 23.22%
3,510,228
JSPR icon
3
Jasper Therapeutics
JSPR
$22.4M
$20.8M 19.52%
585,298
KZR
4
DELISTED
Kezar Life Sciences
KZR
$13.8M 12.94%
82,871
VTYX
5
DELISTED
Ventyx Biosciences
VTYX
$12.4M 11.6%
910,306
ELEV
6
DELISTED
Elevation Oncology
ELEV
$5.97M 5.61%
2,370,142

Similar funds

Qiming U.S. Ventures Management's Q1 2022 Portfolio in Review

As of Q1 2022, Qiming U.S. Ventures Management held 6 positions worth $106M, down 51% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Qiming U.S. Ventures Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Qiming U.S. Ventures Management's ten largest holdings make up 100% of its $106M portfolio in Q1 2022.
  • Qiming U.S. Ventures Management opened 0 new positions and closed 0 in Q1 2022.
  • Qiming U.S. Ventures Management's portfolio value fell 51% quarter-over-quarter to $106M.

Based on Qiming U.S. Ventures Management's 13F filing for Q1 2022, filed 16 May 2022.